ent-Ezetimibe
The lipid-lowering drug, the first and only cholesterol absorption inhibitor, effectively reduces intestinal cholesterol absorption and lowers plasma cholesterol levels as well as hepatic cholesterol stores through selective inhibition of small intestinal cholesterol transporter proteins.
Catalog Number | API1376614991 |
Alternative Name(s) | (3S,4R)-1-(4-Fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one FST3D70Q0D (3S,4R)-1-(4-FLUOROPHENYL)-3-[(3R)-3-(4-FLUOROPHENYL)-3-HYDROXYPROPYL]-4-(4-HYDROXYPHENYL)AZETIDIN-2-ONE |
Research Area | Lipid-Lowering APIs |
Molecular Formula | C24H21F2NO3 |
CAS# | 1376614-99-1 |
SMILES | C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O |
Size | inquiry |
Supplier Page | https://www.protheragen-ing.com/ent-ezetimibe-item-11611.html |